These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21993269)

  • 1. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
    Shafizadeh N; Kakar S
    Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.
    Witjes CD; ten Kate FJ; Verhoef C; de Man RA; IJzermans JN
    J Clin Pathol; 2013 Aug; 66(8):687-91. PubMed ID: 23585667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
    DU JL; Wei LX; Wang YL
    Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
    Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
    Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
    Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
    Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.
    Choi WT; Kakar S
    Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology.
    Bioulac-Sage P; Laumonier H; Rullier A; Cubel G; Laurent C; Zucman-Rossi J; Balabaud C
    Liver Int; 2009 Mar; 29(3):459-65. PubMed ID: 18803590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.
    Nguyen TB; Roncalli M; Di Tommaso L; Kakar S
    Mod Pathol; 2016 Mar; 29(3):283-92. PubMed ID: 26769138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.
    Roskams T; Kojiro M
    Semin Liver Dis; 2010 Feb; 30(1):17-25. PubMed ID: 20175030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.
    Di Tommaso L; Destro A; Seok JY; Balladore E; Terracciano L; Sangiovanni A; Iavarone M; Colombo M; Jang JJ; Yu E; Jin SY; Morenghi E; Park YN; Roncalli M
    J Hepatol; 2009 Apr; 50(4):746-54. PubMed ID: 19231003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
    Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
    Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.
    Ataide EC; Perales SR; Silva MG; Filho FC; Sparapani AC; Latuf Filho PF; Stucchi RSB; Vassallo J; Escanhoela CAF; Boin IFSF
    Transplant Proc; 2017 May; 49(4):858-862. PubMed ID: 28457411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
    Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
    Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.